[S18★☆] Recent trends and future perspectives for non-clinical pharmacokinetics and safety evaluation of therapeutic monoclonal antibodies —at the dawn of a new era

1:59 PM - 2:22 PM JST(4:59 AM - 5:22 AM UTC)

[S18-3] Preclinical DMPK research on next-generation engineered antibodies

○Kenta Haraya¹ (1. Discovery Biologics Department, Research Division, Chugai Pharmaceutical Co., Ltd.)